| pharmacogenomics |
The application of genome science (genomics) to the study of human variability in drug response.
Ãâó: www.genaissance.com/pharmacogenomics/glossary.asp
|
|---|---|
| pharmacogenomics |
The study of how genes interact with drugs. Some people suffer side effects in response to common medications, and others don
Ãâó: www.agingadvantage.com/glossary.html
|
| pharmacogenomics |
The application of genomics information and technologies in drug discovery and development so as to identify, on the basis of genetic make-up, those individuals who will respond most favourably to a drug or those who are at risk of serious side-effects. Also describes the use of genetic approaches to identify drug targets linked to a critical disease pathway and to understand the genetic variation in those targets.
Ãâó: www.oxagen.co.uk/pages/media_investors/6/
|
| pharmacogenomics |
The study of how an individual
Ãâó: medicine.indiana.edu/iu_medicine/03_winter/article...
|
| pharmacogenomics |
the study of the differences among a number of drugs/compounds with regard to a defined gene expression response (ie, genes that dictate drug behavior). The aim of pharmacogenomics is to optimize therapeutic efficiency by predicting an/or interpreting a patient's response to a drug based on his/her genetic (DNA) makeup. The method employed in the realization of this goal is known as genotyping.
Ãâó: www.dominiondiagnostics.com/glossary.htm
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|